Rang	Name	Position
1	Dr. Clay B. Siegall Ph.D.	Chairman, President & CEO
2	Mr. Max Rosett	Chief Financial Officer
3	Dr. Robert J. Lechleider M.D.	Chief Medical Officer
4	Dr. Philip Tsai	Chief Technical Officer
5	Dr. Jack Higgins Ph.D.	Chief Scientific Officer
6	Ms. Sandra G. Stoneman Esq., J.D.	Chief Legal Officer, General Counsel & Corporate Secretary
7	Mr. Roee Shahar	Executive Vice President of Commercial

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	T. Rowe Price Investment Management,Inc.	17,35%	0,38 Mrd. USD
2	FMR Inc	14,98%	0,33 Mrd. USD
3	BlackRock Inc	7,77%	0,17 Mrd. USD
4	State Street Corp	4,85%	0,11 Mrd. USD
5	Wellington Management Company LLP	4,59%	0,10 Mrd. USD
6	Redmile Group, LLC	4,33%	0,10 Mrd. USD
7	PRIMECAP Management Company	4,04%	0,09 Mrd. USD
8	Vanguard Capital Management, LLC	4,01%	0,09 Mrd. USD
9	Driehaus Capital Management LLC	3,83%	0,09 Mrd. USD
10	Enavate Sciences GP, LLC	3,19%	0,07 Mrd. USD
11	Geode Capital Management, LLC	2,43%	0,05 Mrd. USD
12	Morgan Stanley - Brokerage Accounts	2,12%	0,05 Mrd. USD
13	SILVERARC CAPITAL MANAGEMENT, LLC	1,78%	0,04 Mrd. USD
14	JPMorgan Chase & Co	1,63%	0,04 Mrd. USD
15	T. Rowe Price Associates, Inc.	1,56%	0,04 Mrd. USD
16	Sofinnova Ventures	1,52%	0,03 Mrd. USD
17	Readystate Asset Management LP	1,42%	0,03 Mrd. USD
18	The Goldman Sachs Group Inc	1,33%	0,03 Mrd. USD
19	Vanguard Portfolio Management, LLC	1,19%	0,03 Mrd. USD
20	Principal Financial Group Inc	1,19%	0,03 Mrd. USD